Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Ms. Michelle L. Basil

Executive Vice President, General Counsel & Secretary

Ms. Laurie A. Miller

Senior Vice President & Chief Human Resources Officer

Dr. Jan  Hartmann M.D.

Senior Vice President & Chief Medical Officer

Mr. Christopher A. Simon

Chief Executive Officer, President & Director

Mr. Rajeev  Varma

Senior Vice President of Strategy & Corporate Development

Mr. James C. D'Arecca CPA

Chief Financial Officer, Executive Vice President  & Financial Officer

Ms. Anila  Lingamneni

Executive Vice President & Chief Technology Officer

Mr. Josep Lluis Llorens

Executive Vice President of Global Manufacturing & Supply Chain

Ms. Farris Maryanne Maunsell

Vice President, Chief Accounting Officer & Principal Accounting Officer

Ms. Olga  Guyette

Senior Director of Investor Relations

Haemonetics Corporation

Haemonetics Corporation Structuur van het management

Informatie over het management